Literature DB >> 11211228

Expression of type 1 fimbriae (SEF 21) of Salmonella enterica serotype enteritidis in the early colonisation of the rat intestine.

Patrick J Naughton, George Grant, Susan Bardocz, Emma Allen-Vercoe1, Martin J Woodward1, Arpad Pusztai.   

Abstract

The involvement of type 1 fimbriae in colonisation of the rat gastrointestinal tract in vivo was investigated with Salmonella enterica serotype Enteritidis LA5 and a mutant of LA5 denoted EAV3 unable to elaborate type 1 fimbriae (SEF 21). Rats were given a single dose of LA5 or EAV3 or a 1:1 mixture of both. LA5 was found in higher numbers in the stomach and small intestine than EAV3 at 6 h after infection with a single strain, but not after 6 days. LA5 did not out-compete EAV3 when the strains were administered together. Indeed, after 6 and 21 days, EAV3 was found in the distal small intestine and large intestine in far higher numbers than LA5. These findings suggest that SEF 21 have an important role(s) in the early stages of infection in vivo. However, SEF 21 expression may disadvantage the pathogen in the longer term as indicated by EAV3 out-competing LA5 in the gut at 21 days.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11211228     DOI: 10.1099/0022-1317-50-2-191

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  9 in total

1.  FimA, FimF, and FimH are necessary for assembly of type 1 fimbriae on Salmonella enterica serovar Typhimurium.

Authors:  Sarah A Zeiner; Brett E Dwyer; Steven Clegg
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

2.  Effects of nondigestible oligosaccharides on Salmonella enterica serovar Typhimurium and nonpathogenic Escherichia coli in the pig small intestine in vitro.

Authors:  P J Naughton; L L Mikkelsen; B B Jensen
Journal:  Appl Environ Microbiol       Date:  2001-08       Impact factor: 4.792

3.  The Salmonella enterica serotype Typhimurium lpf, bcf, stb, stc, std, and sth fimbrial operons are required for intestinal persistence in mice.

Authors:  Eric H Weening; Jared D Barker; Marijke C Laarakker; Andrea D Humphries; Renée M Tsolis; Andreas J Bäumler
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

4.  Allosteric catch bond properties of the FimH adhesin from Salmonella enterica serovar Typhimurium.

Authors:  Dagmara I Kisiela; Jeremy J Kramer; Veronika Tchesnokova; Pavel Aprikian; Vladimir Yarov-Yarovoy; Steven Clegg; Evgeni V Sokurenko
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

5.  Not just an antibiotic target: Exploring the role of type I signal peptidase in bacterial virulence.

Authors:  Shawn I Walsh; Arryn Craney; Floyd E Romesberg
Journal:  Bioorg Med Chem       Date:  2016-09-21       Impact factor: 3.641

6.  Evolution of Salmonella enterica virulence via point mutations in the fimbrial adhesin.

Authors:  Dagmara I Kisiela; Sujay Chattopadhyay; Stephen J Libby; Joyce E Karlinsey; Ferric C Fang; Veronika Tchesnokova; Jeremy J Kramer; Viktoriya Beskhlebnaya; Mansour Samadpour; Krzysztof Grzymajlo; Maciej Ugorski; Emily W Lankau; Roderick I Mackie; Steven Clegg; Evgeni V Sokurenko
Journal:  PLoS Pathog       Date:  2012-06-07       Impact factor: 6.823

7.  The Novel Type 1 Fimbriae FimH Receptor Calreticulin Plays a Role in Salmonella Host Specificity.

Authors:  Krzysztof Grzymajlo; Maciej Ugorski; Jaroslaw Suchanski; Anna E Kedzierska; Rafal Kolenda; Anna Jarzab; Agnieszka Biernatowska; Peter Schierack
Journal:  Front Cell Infect Microbiol       Date:  2017-07-19       Impact factor: 5.293

8.  Mannanoligosaccharide agglutination by Salmonella enterica strains isolated from carrier pigs.

Authors:  Luciane Borowsky; Gertrudes Corção; Marisa Cardoso
Journal:  Braz J Microbiol       Date:  2009-09-01       Impact factor: 2.476

9.  Novel In Vivo Assessment of Antimicrobial Efficacy of Ciprofloxacin Loaded Mesoporous Silica Nanoparticles against Salmonella typhimurium Infection.

Authors:  Maher N Alandiyjany; Ahmed S Abdelaziz; Ahmed Abdelfattah-Hassan; Wael A H Hegazy; Arwa A Hassan; Sara T Elazab; Eman A A Mohamed; Eman S El-Shetry; Ayman A Saleh; Naser A ElSawy; Doaa Ibrahim
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.